Health care legislation business Frier Levitt has analyzed FDA enforcement actions versus “investigation only” peptide vendors. Their conclusion: the FDA considers an item’s classification determined by its intended use, not its disclaimers. When Web-sites incorporate dosage guides, reconstitution D